Scribd Logo
Upload

Welcome to Scribd!

  • Notice: Applications, Hearings, Determinations, Etc.: Cody Laboratories, Inc.

    Uploaded by

    Justia.com
    10 views1 page
    Notice: Applications, hearings, determinations, etc.: Cody Laboratories, Inc., 36729 [E7-12948] Drug Enforcement Administration

    Original Title

    Notice: Applications, hearings, determinations, etc.: Cody Laboratories, Inc.

    Copyright

    © Public Domain

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Notice: Applications, hearings, determinations, etc.: Cody Laboratories, Inc., 36729 [E7-12948] Drug Enforcement Administration

    Copyright:

    Public Domain
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    10 views1 page

    Notice: Applications, Hearings, Determinations, Etc.: Cody Laboratories, Inc.

    Uploaded by

    Justia.com
    Notice: Applications, hearings, determinations, etc.: Cody Laboratories, Inc., 36729 [E7-12948] Drug Enforcement Administration

    Copyright:

    Public Domain
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Federal Register / Vol. 72, No.

    128 / Thursday, July 5, 2007 / Notices 36729

    DEPARTMENT OF JUSTICE Drug Schedule the basic classes of controlled


    substances listed in schedule I and II:
    Drug Enforcement Administration Codeine (9050) ............................. II
    Dihydrocodeine (9120) ................. II Drug Schedule
    Manufacturer of Controlled Methadone (9250) ........................ II
    Substances; Notice of Application Alfentanil (9737) ........................... II Tetrahydrocannabinols (7370) ..... I
    Benzoylecgonine (9180) ............... II
    Pursuant to § 1301.33(a), Title 21 of The company plans to manufacture in Morphine (9300) ........................... II
    the Code of Federal Regulations (CFR), bulk, for distribution to its customers.
    this is notice that on May 10, 2007, An objection and a request for a The company plans to produce the
    Cambrex Charles City, Inc., 1205 11th hearing were received by the DEA. In listed controlled substances in bulk to
    Street, Charles City, Iowa 50616, made accordance with 21 1301.33 bulk be used in the manufacturer of reagents
    application by letter to the Drug manufacturers applying for or registered and drug calibrator/controls for DEA
    Enforcement Administration (DEA) to in the same basic class of narcotic or exempt products.
    Any other such applicant and any
    be registered as a bulk manufacturer of non-narcotic controlled substances may
    person who is presently registered with
    Morphine (9300), a basic class of submit to the DEA any comments on or
    DEA to manufacture such a substance
    controlled substance listed in schedules objections to the issuance of a proposed may file comments or objections to the
    II. application. This regulation does not issuance of the proposed registration
    The company plans to manufacture provide bulk manufacturers the right to pursuant to 21 CFR 1301.33(a).
    the listed controlled substance for sale request a hearing on the proposed Any such written comments or
    as an intermediate to generic drug application. No hearing was scheduled objections being sent via regular mail
    customers. to be heard on this matter. DEA has should be addressed, in quintuplicate,
    reviewed the objection made against to the Drug Enforcement
    Any other such applicant and any
    this pending application and has Administration, Office of Diversion
    person who is presently registered with
    determined that the registration of Cody Control, Federal Register Representative
    DEA to manufacture such a substance
    Laboratories, Inc. to manufacture the (ODL), Washington, DC 20537, or any
    may file comments or objections to the
    listed basic class of controlled substance being sent via express mail should be
    issuance of the proposed registration
    is consistent with the public interest at sent to Drug Enforcement
    pursuant to 21 CFR 1301.33(a).
    this time. DEA has investigated Cody Administration, Office of Diversion
    Any such written comments or Laboratories, Inc. to ensure that the Control, Federal Register Representative
    objections being sent via regular mail company’s registration is consistent (ODL), 2401 Jefferson Davis Highway,
    should be addressed, in quintuplicate, with the public interest. The Alexandria, Virginia 22301; and must be
    to the Drug Enforcement investigation has included inspection filed no later than September 4, 2007.
    Administration, Office of Diversion and testing of the company’s physical
    Control, Federal Register Representative Dated: June 26, 2007.
    security systems, verification of the
    (ODL), Washington, DC 20537, or any company’s compliance with state and Joseph T. Rannazzisi,
    being sent via express mail should be local laws, and a review of the Deputy Assistant Administrator, Office of
    sent to Drug Enforcement company’s background and history. Diversion Control, Drug Enforcement
    Administration, Office of Diversion Administration.
    Therefore, pursuant to 21 U.S.C. 823,
    Control, Federal Register Representative and in accordance with 21 CFR 1301.33, [FR Doc. E7–12960 Filed 7–3–07; 8:45 am]
    (ODL), 2401 Jefferson-Davis Highway, the above named company is granted BILLING CODE 4410–09–P
    Alexandria, Virginia 22301; and must be registration as a bulk manufacturer of
    filed no later than September 4, 2007. the basic class of controlled substance
    DEPARTMENT OF JUSTICE
    Dated: June 26, 2007. listed.
    Joseph T. Rannazzisi, Dated: June 26, 2007. Drug Enforcement Administration
    Deputy Assistant Administrator, Office of Joseph T. Rannazzisi,
    Diversion Control, Drug Enforcement Deputy Assistant Administrator, Office of
    Manufacturer of Controlled
    Administration. Diversion Control, Drug Enforcement Substances; Notice of Application
    [FR Doc. E7–12966 Filed 7–3–07; 8:45 am] Administration. Pursuant to § 1301.33(a) of Title 21 of
    BILLING CODE 4410–09–P [FR Doc. E7–12948 Filed 7–3–07; 8:45 am] the Code of Federal Regulations (CFR),
    BILLING CODE 4410–09–P this is notice that on March 28, 2007,
    Lin Zhi International Inc., 687 North
    DEPARTMENT OF JUSTICE
    Pastoria Avenue, Sunnyvale, California
    DEPARTMENT OF JUSTICE 94085, made application by renewal to
    Drug Enforcement Administration
    the Drug Enforcement Administration
    Drug Enforcement Administration
    Manufacturer of Controlled (DEA) to be registered as a bulk
    Substances; Notice of Registration Manufacturer of Controlled manufacturer of the basic classes of
    Substances; Notice of Application controlled substances listed in schedule
    By Notice dated April 18, 2006, and I and II:
    published in the Federal Register on Pursuant to § 1301.33(a) of Title 21 of
    April 25, 2006, (71 FR 23948), Cody the Code of Federal Regulations (CFR), Drug Schedule
    Laboratories, Inc., 601 Yellowstone this is notice that on May 1, 2007, Dade
    Avenue, Cody, Wyoming 82414, made Behring Inc., Regulatory Affairs, Quality Tetrahydrocannabinols (7370) ..... I
    sroberts on PROD1PC70 with NOTICES

    3,4– I
    application by letter to the Drug Systems, 20400 Mariani Avenue, Methylenedioxymethamphetam-
    Enforcement Administration (DEA) to Cupertino, California 95014, made ine (7405).
    be registered as a bulk manufacturer of application by renewal to the Drug Cocaine (9041) ............................. II
    the basic classes of controlled Enforcement Administration (DEA) to Oxycodone (9143) ........................ II
    substances listed in schedule II: be registered as a bulk manufacturer of Hydrocodone (9193) ..................... II

    VerDate Aug<31>2005 18:43 Jul 03, 2007 Jkt 211001 PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\05JYN1.SGM 05JYN1

    You might also like